Display search results for ** instead (42 products)

Showing 1-10 of 42

12 Oct 2021  |  North America

Global Structural Heart Devices Growth Opportunities

The Rise of Disruptive Technologies Driven by Increasing Competitive Intensity

A plethora of percutaneous treatment approaches has led to clinical care innovations in cardiac interventions. The past decade witnessed more applications of novel, catheter-based treatments for structural heart diseases. Many of these non-surgical, catheter-based interventional procedures have been proven effective, consequently resulting in great...

USD 4,950.00
20 Sep 2021  |  North America

Global In Vitro Diagnostics Market Outlook, 2021

Personalized Diagnostics and Increased Healthcare Investment to Drive Market Growth Post COVID-19 Pandemic

The change in reimbursement for diagnostic testing, pressure from PAMA, regulatory trends in Europe, demand for large-scale testing, shift to precision diagnostics, emerging companies, and evolving business models demand assessing portfolio, evaluating competitor strategies, and exploring opportunities for business growth. The competitive nature of...

USD 4,950.00
13 Sep 2021  |  North America

Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Growth Opportunities

Emerging Pharmaceuticals and Highly Potent Complex Molecules Creating Future Growth Potential

This study presents Frost & Sullivans overall market and segment-wise revenue forecasts of the global small molecule contract development and manufacturing organization (CDMO) industry. It highlights key growth opportunities for small molecule CDMOs based on the main evolution in their business models and strategic approaches as well as those of ph...

USD 4,950.00
09 Sep 2021  |  North America

Global Medical Device Leasing Growth Opportunities

Vendors' Integration of Support Services and Shift from Product-centric to Value-oriented Business Models will Improve ROI and Margins for Healthcare Providers

Globally, hospitals and health systems face financial pressure caused by high operating and administrative costs, declining revenue and reimbursement rates, and the increasing cost of both medical devices (due to technology advancements) and infrastructure. The COVID-19 pandemic has intensified this financial crisis as patient volumes dropped and n...

USD 2,450.00
03 Sep 2021  |  North America

Global Renal Care Management Growth Opportunities

Value-based Renal Care to be a Key Growth Area

The global prevalence of CKD is estimated to be about 9% to 10%. Chronic Kidney Disease (CKD) is associated with poor outcomes, mainly due to the high burden of comorbidity. Along with rising aging population, increasing number of CKD patients are suffering from comorbidities such as hypertension, diabetes, heart failure, cancer, and mental ill hea...

USD 4,950.00
27 Aug 2021  |  North America

US and EU Upstream Bioprocessing Growth Opportunities

Increasing Demand for Consumables and Single-use Technologies to Drive Growth in Upstream Bioprocessing

The Transformational Health team at Frost & Sullivan provides critical insights into the US and EU upstream bioprocessing market, highlighting drug demand trends, installed capacity developments, market revenue forecast by various segments, competitive landscape, and key growth opportunities that currently exist or are set to develop during the for...

USD 4,950.00
24 Aug 2021  |  North America

US and EU Biotech Industry VC Investment Growth Opportunities

Future Growth Potential Driven by Next-generation Cell and Gene Platform Technology Powered by AI

With this research service, Frost & Sullivan provides critical insights into the biotech, and cell and gene therapy (CGT) venture capital (VC) investment trends highlighting the growth opportunities, key countries in the VC environment, and major trends in cell and gene therapy segment. The study also identifies actionable growth opportunities for ...

USD 2,450.00
16 Aug 2021  |  North America

Global Drug Discovery and Early Development Outsourcing Growth Opportunities

Growing Research and Development Pipelines of Emerging Biopharmaceutical and Niche Technology Providers Drive Competitive Intensity

Frost & Sullivan presents post-COVID-19 growth opportunities and strategic imperatives for the global drug discovery and early development outsourcing market in this study, which covers research and development (R&D) efforts, market trends, key participants, drivers and restraints of market adoption, and recent mergers and acquisitions. The report ...

USD 4,950.00
12 Aug 2021  |  North America

Frost Radar™: Non-Invasive Prenatal Testing, Global, 2021

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Non-invasive prenatal testing (NIPT) provides an alternative to invasive, higher-risk tests such as amniocentesis, requiring a maternal blood sample to obtain cell-free DNA from both mother and fetus for analysis. Since NIPTs debut in 2011, laboratories and testing companies have made incremental upgrades to their non-invasive screens, improving ac...

USD 4,950.00
04 Aug 2021  |  North America

Growth Opportunities Arising due to the Use of Commercial AI Models in Radiology

The Intensely Competitive Landscape Necessitates the Repositioning of Value Through the Acceptance of New Business Models

As artificial intelligence (AI) solutions gain acceptance in the imaging fraternity and among senior leaders in the health systems space, competition has intensified and necessitated the creation of differentiation strategies for companies that want to improve their revenue and sustain growth. The rapid proliferation of medical imaging AI companies...

USD 2,450.00

Showing 1-10 of 42